HRH3 and early-onset autosomal dominant Alzheimer disease: Therefore, H3R can be a potential therapeutic target for various diseases such as sleep-wake disorders including narcolepsy, attention-deficit hyperactivity disorder, Alzheimer’s disease, and schizophrenia [7–9].